MedPath

TEVA-NEVIRAPINE

TEVA-NEVIRAPINE

Discontinued
DIN Number

02352893

Drug Class

Human

Market Date

Feb 1, 2011

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352893
AIG Number0134602001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AG01 NEVIRAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

NEVIRAPINEActive
Strength: 200 MG
Monograph: NEVIRAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.